Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Time for consolidation in Germany

Commercial biotechnology in Germany has taken off during the past decade, but creating a viable sector may require a change in strategy in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Biotechnology companies in Germany and the United Kingdom, 1995–2000.

© Amy Center

References

  1. Müller, C. The evolution of the biotechnology industry in Germany. Trends Biotechnol. In press, July, 2002

  2. Sontheimer, G. & Matzen, T.J.C. Venture Capital-Finanzierung, in Herstatt, C. & Müller, C. Management-Handbuch Biotechnologie (Schäffer-Poeschel, Stuttgart; 2002)).

    Google Scholar 

  3. The Boston Consulting Group. Positionierung deutscher Biotechnologie-Cluster im internationalen Vergleich (January 2001).

  4. Herstatt, C. & Müller, C. Management-Handbuch Biotechnologie (Schäffer-Poeschel, Stuttgart; 2002).

    Google Scholar 

  5. Fletcher, L. Nat. Biotechnol. 20, 211 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, C., Rump, A. Time for consolidation in Germany. Nat Biotechnol 20, 441–444 (2002). https://doi.org/10.1038/nbt0502-441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0502-441

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing